scholarly article | Q13442814 |
P50 | author | David M Schuster | Q42229296 |
P2093 | author name string | Mark M Goodman | |
Peter T Nieh | |||
Viraj A Master | |||
Bital Savir-Baruch | |||
Leah M Bellamy | |||
Raghuveer K Halkar | |||
Melinda M Lewis | |||
Michelle Faurot | |||
Pooneh Taleghani | |||
Rianot Amzat | |||
P2860 | cites work | Mechanisms of bone metastasis | Q33977526 |
Malignant Ascites Associated with Carcinoma of the Prostate. | Q39514709 | ||
Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design | Q39985462 | ||
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma | Q40186415 | ||
A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer | Q40186421 | ||
Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip. | Q42082921 | ||
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. | Q51753150 | ||
Prostate cancer metastatic to the omentum | Q74684193 | ||
P433 | issue | 9 | |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
P304 | page(s) | 800-802 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | Clinical Nuclear Medicine | Q15752866 |
P1476 | title | Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. | |
P478 | volume | 36 |
Q38924532 | Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial |
Q30466368 | Endoscopic imaging of Cerenkov luminescence |
Q33836426 | PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models |
Q37244969 | Translational Molecular Imaging of Prostate Cancer |